Skip to main content

Wine Components Normalize the Cytochrome P450 Content in the Liver and Kidneys of Rats Under Neurogenic Stress

  • Conference paper
  • First Online:
Advanced Bioactive Compounds Countering the Effects of Radiological, Chemical and Biological Agents

Abstract

A majority of organic environmental contaminants need to undergo the metabolic activation to exert their biological effects (toxic, mutagenic, transforming, etc.). This activation is catalyzed by monooxygenase system, which functional element is cytochrome P450 superfamily. One of the important properties of monooxygenase system is the ability of induction under the influence of external stimuli. Xenobiotics, different physiological factors, and stress can act as these stimuli. In our work, we studied cytochrome P450 content in the organs of the experimental animals under acute neurogenic stress and under the influence of alcohol and grape polyphenols. The obtained results showed that stressed animals had the low liver cytochrome P450 content compared with intact animals. Ethanol administration caused increasing of cytochrome P450 content in the liver of intact and stressed rats. Polyphenolic concentrate Enoant normalized the cytochrome P450 content in liver, whereas grape wines Cabernet and Rkatsiteli significantly increased cytochrome P450 content in both intact and stressed animals. The prophylactic administration of polyphenol concentrates to control animals did not significantly influence the cytochrome P450 content in hepatocytes and in rat kidneys. The cytochrome P450 content significantly decreased in animal kidneys under emotional-pain stress, but this effect was attenuated by ethanol administration. Incubation of isolated hepatocytes in the presence of phenacetin was accompanied by increased levels of cytochrome P450 in the cells. Grape polyphenols reduced cytochrome P450 content in the cells in dose-dependent and environment (e.g. stress, ethanol administration)-dependent manners, which suggests their possible role in the cancer prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kalra BS (2007) Cytochrome P450 enzyme isoforms and their therapeutic implications: an update. Ind J Med Sci 61:102–116

    Article  Google Scholar 

  2. Pirmohamed M, Park BK (2003) Cytochrome P450 enzyme polymorphism and adverse drug reactions. Toxicology 192:23–32

    Article  PubMed  CAS  Google Scholar 

  3. Chang GW, Kam PC (1999) The physiological and pharmacological role of CYP450 isoenzymes. Anesthesia 54:42–50

    Article  CAS  Google Scholar 

  4. Maréchal JD, Kemp CA, Roberts GC et al (2007) Insights into drug metabolism by cytochromes P450 from modeling studies of CYP2D6-drug interactions. Br J Pharmacol 153:S82–S89

    Article  PubMed  Google Scholar 

  5. Modi S, Paine MJ, Sutcliffe MJ et al (1996) A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. Biochemistry 35:4540–4550

    Article  PubMed  CAS  Google Scholar 

  6. Meunier B, de Visser SP, Shaik S (2004) Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. Chem Rev 104:3947–3980

    Article  PubMed  CAS  Google Scholar 

  7. Werck-Reichhart D, Feyereisen R (2000) Cytochromes P450: a success story. Gen Biol 1:reviews3003.1–reviews3003

    Google Scholar 

  8. Degtyarenko KN (1995) Structural domains of P450-containing monooxygenase systems. Protein Eng 8:737–747

    Article  PubMed  CAS  Google Scholar 

  9. Yan Z, Caldwell GW (2001) Metabolism profiling and cytochrome P450 inhibition and induction in drug discovery. Curr Topics Med Chem 1:403–425

    Article  CAS  Google Scholar 

  10. Sørensen JM (2002) Herb-drug, food-drug, nutrient-drug, and drug-drug interactions: mechanisms involved and their medical implications. J Altern Complement Med 8:293–308

    Article  PubMed  Google Scholar 

  11. Munasinghe TM (2002) Adverse drug reactions: monitoring, reporting and prevention. Ceylon Med J 47:19–21

    PubMed  CAS  Google Scholar 

  12. Johnson JA, Herring VL, Wolfe MS et al (2000) CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences. Pharmacol Exp Ther 294:1099–1105

    CAS  Google Scholar 

  13. Vuilleumier N, Rossier MF, Chiappe A et al (2006) CYP2E1 genotype and isoniazid-induced hepatotoxicity in patient treated for latent tuberculosis. Eur J ClinPharmacol 62:423–429

    Article  CAS  Google Scholar 

  14. Dai Y, Cederbaum AI (1995) Cytotoxicity of acetaminophen in human cytochrome P450 2E1-transfected HepG2 cells. J Pharmacol Exp Ther 273:1497–1505

    PubMed  CAS  Google Scholar 

  15. Adhvaryu MR, Reddy N, Parabia MH (2007) Effects of four Indian medicinal herbs on isoniazid-­and pyrazinamide-induced hepatic injury and immunosuppression in guinea pigs. Word J Gastroenterol 13:3199–3205

    Google Scholar 

  16. Meeran SM, Katiyar S, Elmets CA et al (2006) Silymarin inhibits UV radiation induced immunosuppression through augmentation of interleukin-12 in mice. Mol Cancer Ther 5:1660–1668

    Article  PubMed  CAS  Google Scholar 

  17. Trierweiler J, Göttert DN, Gehlen G (2012) Evaluation of mechanical allodynia in an animal immobilization model using the Von Frey method. J Manipul Physiol Ther 35:18–25

    Article  Google Scholar 

  18. Raghavendran HB, Sathivel A, Devaki T (2006) Defensive nature of Sargassum polycystum (Brown algae) against acetaminophen-induced toxic hepatitis in rats: role of drug metabolizing microsomal enzyme system, tumor necrosis factor-alpha and fate of liver cell structural integrity. World J Gastroenterol 12:3829–3834

    PubMed  CAS  Google Scholar 

  19. OmuraT SR (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370–2378

    Google Scholar 

  20. Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    PubMed  CAS  Google Scholar 

  21. Seglen PO (1993) Isolation of hepatocytes by collagenase perfusion. Methods Toxicol 1A:231–243

    Google Scholar 

  22. David JP (2005) The molecular toxicology of acetaminophen. Drug Metab Rev 37:581–594

    Article  Google Scholar 

  23. Xu J, Hwang JC, Lees HA et al (2012) Long-term perturbation of muscle iron homeostasis following hind limb suspension in old rats is associated with high levels of oxidative stress and impaired recovery from atrophy. Exp Gerontol 47:100–108

    Article  PubMed  CAS  Google Scholar 

  24. Tang H, Sebastian BM, Axhemi A et al (2012) Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes. Alcohol Clin Exp Res 36:214–222

    Article  PubMed  CAS  Google Scholar 

  25. Navasumrit P, Ward TH, Dodd NJ et al (2000) Ethanol-induced free radicals and hepatic DNA strand breaks are prevented in vivo by antioxidants: effects of acute and chronic ethanol exposure. Carcinogenesis 21:93–99

    Article  PubMed  CAS  Google Scholar 

  26. Khan AJ, Ruwali M, Choudhuri G et al (2009) Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis. Mutat Res 664:55–63

    Article  PubMed  CAS  Google Scholar 

  27. Nichols KD, Kirby GM (2008) Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress. Biochem Pharmacol 75:1230–1239

    Article  PubMed  CAS  Google Scholar 

  28. Cowpland C, Su GM, Murray M et al (2006) Effect of alcohol on cytochrome p450 arachidonic acid metabolism and blood pressure in rats and its modulation by red wine polyphenolics. Clin Exp Pharmacol Physiol 33:183–188

    Article  PubMed  CAS  Google Scholar 

  29. Smith C, Stamm SC, Riggs JE et al (2000) Ethanol-mediated CYP1A1/2 induction in rat skeletal muscle tissue. Exp Mol Pathol 69:223–232

    Article  PubMed  CAS  Google Scholar 

  30. Tsuji PA, Walle T (2007) Benzo[a]pyrene-induced cytochrome P450 1A and DNA binding in cultured trout hepatocytes - inhibition by plant polyphenols. Chem Biol Interact 169:25–31

    Article  PubMed  CAS  Google Scholar 

  31. Anttila S, Raunio H, Hakkola J (2011) Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-talk in lung carcinogenesis. Am J Respir Cell Mol Biol 44:583–590

    Article  PubMed  CAS  Google Scholar 

  32. Kishida T, Nagamoto M, Ohtsu Y et al (2004) Lack of an inducible effect of dietary soy isoflavones on the mRNA abundance of hepatic cytochrome P-450 isozymes in rats. Biosci Biotechnol Biochem 68:508–515

    Article  PubMed  CAS  Google Scholar 

  33. Donato MT, Hallifax D, Picazo L et al (2010) Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo. Drug Metab Dispos 38:1449–1455

    Article  PubMed  CAS  Google Scholar 

  34. Kirchmair J, Williamson MJ, Tyzack JD et al (2012) Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. J Chem Inf Model 52:617–648

    Article  PubMed  CAS  Google Scholar 

  35. Lu H, Gonzalez FJ, Klaassen C (2010) Alterations in hepatic mRNA expression of phase II enzymes andxenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha. Toxicol Sci 118:380–390

    Article  PubMed  CAS  Google Scholar 

  36. McFadyen MC, Melvin WT, Murray GI (2004) Cytochrome P450 CYP1B1 activity in renal cell carcinoma. Br J Cancer 91:966–971

    PubMed  CAS  Google Scholar 

  37. Takanaga H, Ohnishi A, Yamada S et al (2000) Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. J Pharmacol Exp Ther 293:230–236

    PubMed  CAS  Google Scholar 

  38. Allen SW, Mueller L, Williams SN et al (2001) The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression. Drug Metab Dispos 29:1074–1079

    PubMed  CAS  Google Scholar 

  39. Bartik L, Whitfield GK, Kaczmarska M et al (2010) Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem 21:1153–1161

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrey Zagayko .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media Dordrecht

About this paper

Cite this paper

Zagayko, A., Krasilnikova, O., Kravchenko, A. (2013). Wine Components Normalize the Cytochrome P450 Content in the Liver and Kidneys of Rats Under Neurogenic Stress. In: Pierce, G., Mizin, V., Omelchenko, A. (eds) Advanced Bioactive Compounds Countering the Effects of Radiological, Chemical and Biological Agents. NATO Science for Peace and Security Series A: Chemistry and Biology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6513-9_25

Download citation

Publish with us

Policies and ethics